Trial Details

TERMINATED
Basic Information
Clinical ID c4649
Identifier NCT00206700
Trial Title Open-label Trial of Leukine in Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: Sargramostim (Leukine)
Participant Information
Sponsor Genzyme, a Sanofi Company
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2003-02
Primary Completion Date 2006-12
Completion Date 2006-12